Anti-Leishmania activated C-kinase monoclonal antibody immunohistochemical technique for cutaneous leishmaniasis diagnosis
PLOS One · 05.08.2026 · 21 (8) · e0339746
DOI: 10.1371/journal.pone.0339746 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 05.08.2026. Verfasst von Amanda Desirée Lopes Santos und 11 weiteren Autor:innen. Beteiligte Einrichtung: Grupo de Genômica Funcional de Parasitos, Instituto René Rachou, Fundação Oswaldo Cruz, Fiocruz, Belo Horizonte, Minas Gerais, Brazil. Hauptthemen laut MEDLINE: Leishmaniasis, Cutaneous, Immunohistochemistry, Antibodies, Monoclonal, Antigens, Protozoan. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de Minas Gerais, Instituto René Rachou, Fundação Oswaldo Cruz, Fiocruz, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
This study aimed to develop and validate an immunohistochemistry (IHC) technique using a monoclonal antibody (mAb) against the Leishmania homolog of activated C kinase (LACK) antigen (anti-LACK IHC) for the diagnosis of cutaneous leishmaniasis (CL). The Leishmania braziliensis LACK sequence (A4HGX7_LEIBR) was analyzed for B-cell epitope prediction, and three antigenic regions were selected to design a multiepitope antigen. The corresponding gene was back-translated, synthesized, and cloned into the pET28a(+) plasmid. Recombinant LACK protein was expressed and used as an immunogen for mAb production by somatic hybridization. The ability of the anti-LACK mAb to recognize native LACK and amastigotes of Leishmania (Leishmania) amazonensis , Leishmania (Viannia) braziliensis , and Leishmania (Viannia) guyanensis was confirmed by Western blotting using total parasite extracts and by IHC in skin histological sections from experimentally infected hamsters. Subsequently, the anti-LACK IHC assay was validated using skin lesion samples from 104 patients with suspected CL who attended the outpatient clinic of the Municipal Polyclinic of Teófilo Otoni, Brazil, between 2019 and 2020, using kDNA-PCR as the reference standard. The diagnostic performance of anti-LACK IHC was compared with direct examination (DE) and conventional histopathology (HE). Anti-LACK IHC showed a sensitivity of 59.3% (95% CI: 40.0–83.7), numerically higher than DE (53.7; p = 0.55) and HE (42.6; p = 0.08). The specificity of the anti-LACK IHC was 98.0% (95% CI: 89.5–99.7), equal to the DE (98.0%) and slightly higher to the HE (96.0%), but without statistically significant difference ( p = 0.56). The accuracy was of 77.9% (95% CI: 61.9–96.8) with anti-LACK IHC, 75.0% with DE ( p = 0.62) and 68.3% with HE ( p = 0.12). The combination of anti-LACK IHC with DE or HE numerically increased diagnostic accuracy to 83.7% ( p = 0.48) and 79.8% ( p = 0.33), respectively. The results demonstrated that anti-LACK IHC was able to detect the main Leishmania species responsible for CL in Brazil and further studies may prove its applicability in the CL diagnosis routine in different Brazilian endemic regions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Grupo de Genômica Funcional de Parasitos, Instituto René Rachou, Fundação Oswaldo Cruz, Fiocruz, Belo Horizonte, Minas Gerais, Brazil.
- Grupo de Imunologia das Doenças Virais, Instituto René Rachou, Fundação Oswaldo Cruz, Fiocruz, Belo Horizonte, Minas Gerais, Brazil.
- Departamento de Anatomia Patológica e Medicina Legal, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
- Grupo Integrado de Pesquisas em Biomarcadores, Instituto René Rachou, Fundação Oswaldo Cruz, Fiocruz, Belo Horizonte, Minas Gerais, Brazil.
- Serviço de Atendimento Especializado Ampliado -SAE-A, Teófilo Otoni, Minas Gerais, Brazil.
- Secretaria Municipal de Saúde, Teófilo Otoni, Minas Gerais, Brazil.
ORCID-Profile: Edward Oliveira
Förderung
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
- Instituto René Rachou, Fundação Oswaldo Cruz, Fiocruz
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- This publication was supported by the Fundação de Amparo à Pesquisa do Estado de Minas Gerais
Zitieren
APA
Santos, A. D. L., Pascoal-Xavier, M. A., Peruhype-Magalhães, V., Eller, M. T. C., Pereira, F. R. V., Rodrigues, M. P., Brito, M. N. P., E Silva, B. O. S., Silva, T. R. D., Avelar, D. M., Freire, M. L., & Oliveira, E. (2026). Anti-Leishmania activated C-kinase monoclonal antibody immunohistochemical technique for cutaneous leishmaniasis diagnosis. PLOS One, 21(8), e0339746. https://doi.org/10.1371/journal.pone.0339746
Vancouver
Santos ADL, Pascoal-Xavier MA, Peruhype-Magalhães V, Eller MTC, Pereira FRV, Rodrigues MP, et al. Anti-Leishmania activated C-kinase monoclonal antibody immunohistochemical technique for cutaneous leishmaniasis diagnosis. PLOS One. 2026;21(8):e0339746. doi:10.1371/journal.pone.0339746
BibTeX
@article{Santos2026,
author = {Santos, Amanda Desirée Lopes and Pascoal-Xavier, Marcelo Antônio and Peruhype-Magalhães, Vanessa and Eller, Marcela Tavares Caldas and Pereira, Francislane Ramalho Varella and Rodrigues, Maryana Prates and Brito, Maria Nilza Pereira de and E Silva, Bruno Oliveira Souza and Silva, Thadeu Ramalho da and Avelar, Daniel Moreira de and Freire, Mariana Lourenço and Oliveira, Edward},
title = {Anti-Leishmania activated C-kinase monoclonal antibody immunohistochemical technique for cutaneous leishmaniasis diagnosis},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {8},
pages = {e0339746},
doi = {10.1371/journal.pone.0339746}
}
EUVIMED